What are Stem Cells?
Every cell in our body first began as a stem cell, and through the process of differentiation, grew and changed into its ultimate form. Stem cells are “undifferentiated,” meaning they still have the potential to grow into any cell type in the body. Stem cells are located throughout the body in almost every organ and tissue, and can change into any healthy cell in our body. At Williams Integracare we utilize two primary stem cell therapy treatments. Adipose-derived stem cell therapy and bone marrow aspirate concentrate (BMAC) therapy. Both stem cell therapy treatments at Williams Integracare are utilizing each individuals own stem cells from their body. Your specific case will determine the appropriate path for which stem cell treatment we recommend for you.
Common Areas Treated with Stem Cells
Capabilities of Stem Cells
Stem cells travel to sites of injury by cell signals that attract them. Once they reach where they need to go, they dock and start repairing the injury/disease by releasing cytokines, chemokines, and growth factors that signal your immune system to start injury repair. There are greater than 300,000 peer-reviewed scientific publications on Pubmed.gov, discussing positive outcomes following the use of stem cells.
The Use of Stem Cells in Orthopedics
Conditions that have the ability to be treated with Stem Cell Therapy
- Osteoarthritis of the joints including hip, knee, ankle, wrist and shoulder.
- Rotator cuff tears
- Labral tears of hip or shoulder
- Meniscus tears of knee
- Spine disorders, including sciatica and degenerative disc disease
- Tennis elbow/Golfers elbow
- Plantar fasciitis
- Other ligament or tendon tears
- Muscle injuries.
- Fracture repair
- Safety and Complications Reporting on the Re-implantation of Culture-Expanded Mesenchymal Stem Cells using Autologous Platelet Lysate Technique
- Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial
- Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells
- Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study